In May, long-time Pharmacy Quality Alliance (PQA) member AllazoHealth joined healthcare professionals at PQA’s annual meeting. In addition to annual meetings, AllazoHealth has previously joined PQA’s leadership summits with other key individuals from the member organizations to discuss upcoming goals, initiatives, and objectives.
The recent three-day annual meeting was held to advance healthcare quality by addressing issues and trends related to technology, care transformation, and medication quality. In this article, we’ll take a look at each of the main points discussed at PQA’s annual meeting to provide a clear understanding of patient outreach practices and how technologies such as ours can advance medication adherence.
Key Topics Discussed at the PQA Annual Meeting
Better health outcomes occur when a patient is engaged in their care, satisfied with their experience, and is able to achieve their full health potential. Here are three main topics discussed at the annual meeting and how they can impact a patient’s journey.
Although evidence increasingly shows that medication adherence is associated with health outcomes, more research is needed to fully understand the overall patient experience with medication reviews and patient-reported outcomes. Additionally, there is a demonstrated need for an actual measure of patient-reported outcomes and patient experience. PQA is currently talking with patients to better understand their experiences. This information will then be used to build a tool that will measure each patient’s experience related to medication reviews.
Part of delivering better care and understanding the patient experience is understanding that no two patients have the same needs, and some patients may experience significant barriers that prevent them from fully adhering to their medication. Along with a better understanding of what a patient is experiencing, strategies need to be implemented to ensure they are not disadvantaged because of adherence barriers and are receiving what they need to be successful with adhering to their medication.
One of the greatest barriers is cost. For patients with rare conditions who rely on specialty drugs, the cost can be extreme and result in non-adherence. This is especially concerning because approximately 75% of the 7,000 prescription medications currently in development are specialty drugs.
To help improve adherence and affordability, health plans and PBMs can identify savings or bridge programs to help with gaps in coverage. Additionally, non-profit organizations such as Accessia Health can aid with the cost of medical expenses.
Discussing a patient’s goals, adherence barriers, and treatment beliefs is vital to successful patient interventions. A supportive relationship between clinicians and patients can help patients feel more comfortable asking questions, especially because a patient may feel ashamed about their low health literacy.
Since many medications for rare or chronic conditions such as rheumatoid arthritis are new, awareness may be limited. That’s why it’s crucial to raise awareness and educate providers to ensure that patients are receiving medications once they become available.
Additionally, it’s crucial to make sure patients and caregivers have the appropriate educational resources needed to help them understand their disease and the prescribed treatment. Being proactive and educating patients on side effects and how to properly administer medications is key to supporting patients and improving health outcomes while eliminating any potential shame about low health literacy.
AllazoHealth’s Founder and Chief Technology Officer Clifford Jones led a presentation at the annual meeting on “Best Practices in Coordinating Outreach Between Specialty Pharmacies and Manufacturers.” The presentation discussed that both pharmaceutical companies and specialty pharmacies are trying to help patients with filling prescriptions, benefits, and supporting medication adherence.
Coordination of data, intervention targeting, and execution of supportive processes between these organizations are integral to successful patient support programs. For effective data coordination, the following data points must be shared:
- Prescriptions and prescription fills
- Patient and insurance information
- Patient status
- Intervention activity
The best intervention must be coordinated between patients, prescribers, and caregivers, while they align on timing to avoid multiple outreaches on the same day. To do this, it must be determined which organization is doing what task—for example, who is running benefit investigations and who is communicating the status to the patient? Further, content must be reviewed together to eliminate any potential for confusion.
Tools such as artificial intelligence (AI) can help personalize patient interventions while ensuring a seamless approach. After receiving patient permission to share data, a third-party system can be built to create the most complete view of the patient’s experience. Then technology can be implemented to determine specific patient outreaches and to coordinate resources with patient outreach programs.
Personalizing Interventions with AllazoHealth’s AI
Pharmaceutical companies, pharmacies, payers, and PBMs use AllazoHealth’s AI engine to optimize patient support programs. With personalization and better targeting, healthcare organizations can deliver a cost-effective, efficient outreach program.
Want to learn more about AI-powered outreach? Download our AI intervention case study to learn more about how AI-powered interventions made an impact on patient adherence.